Abstract
Iron is one of the important trace elements in life activities. Abnormal iron metabolism increases the incidence of many skeletal diseases, especially for osteoporosis. Iron metabolism plays a key role in the bone homeostasis. Disturbance of iron metabolism not only promotes osteoclast differentiation and apoptosis of osteoblasts but also inhibits proliferation and differentiation of osteoblasts, which eventually destroys the balance of bone remodeling. The strength and density of bone can be weakened by the disordered iron metabolism, which increases the incidence of osteoporosis. Clinically, compounds or drugs that regulate iron metabolism are used for the treatment of osteoporosis. The goal of this review summarizes the new progress on the effect of iron overload or deficiency on osteoporosis and the mechanism of disordered iron metabolism on osteoporosis. Explaining the relationship of iron metabolism with osteoporosis may provide ideas for clinical treatment and development of new drugs.
Similar content being viewed by others
Abbreviations
- DMT1:
-
divalent metal transporter 1
- FPN:
-
ferroportin
- Tf:
-
transferrin
- TfR1:
-
transferrin receptor 1
- STEAP:
-
six-transmembrane epithelial antigen of the prostate
- FtMt:
-
mitochondria-specific Ft type
- IRPs:
-
iron-regulatory proteins
- IREs:
-
iron-responsive elements
- BMP:
-
bone morphogenetic protein
- RANKL:
-
receptor activator of nuclear factor κB
- OPG:
-
osteoprotegerin
- ALP:
-
Alkaline phosphatase
- Runx2:
-
Runt-related transcription factor 2
- OCN:
-
osteocalcin
- BSP:
-
bone sialoprotein
- ROS:
-
reactive oxygen species
- MAPKs:
-
mitogen-activated protein kinase
- ERK1/2:
-
extracellular signal-regulated kinases
- JNK:
-
c-Jun-N-terminal kinase
- BALP:
-
bone-specific alkaline phosphatase
- OC:
-
osteocalcin
- P1NP:
-
N-terminal propeptide of type I procollagen
- OVX:
-
ovariectomized
- BMD:
-
bone minimum density
- MMP9:
-
matrix metalloproteinase 9
- CTSK:
-
cathepsin K
- DFO:
-
desferrioxamine
- HIF:
-
hypoxia-inducible factor
References
Muckenthaler MU, Rivella S, Hentze MW, Galy B (2017) A red carpet for iron metabolism. Cell 168(3):344–361. https://doi.org/10.1016/j.cell.2016.12.034
Andrews NC, Schmidt PJ (2007) Iron homeostasis. Annu Rev Physiol 69:69–85. https://doi.org/10.1146/annurev.physiol.69.031905.164337
Shaw JG, Friedman JF (2011) Iron deficiency anemia: focus on infectious diseases in lesser developed countries. Anemia 2011:260380. https://doi.org/10.1155/2011/260380
Bo L, Liu Z, Zhong Y, Huang J, Chen B, Wang H, Xu Y (2016) Iron deficiency anemia’s effect on bone formation in zebrafish mutant. Biochem Biophys Res Commun 475(3):271–276. https://doi.org/10.1016/j.bbrc.2016.05.069
Klip IT, Voors AA, Swinkels DW, Bakker SJ, Kootstra-Ros JE, Lam CS, van der Harst P, van Veldhuisen DJ, van der Meer P (2017) Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community. Eur J Heart Fail 19(3):348–356. https://doi.org/10.1002/ejhf.622
Li GF, Pan YZ, Sirois P, Li K, Xu YJ (2012) Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int 23(10):2403–2408. https://doi.org/10.1007/s00198-012-1982-1
Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045–1060. https://doi.org/10.1016/S1474-4422(14)70117-6
An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L, Chen B (2016) Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci 147:46–58. https://doi.org/10.1016/j.lfs.2016.01.024
Balogh E, Tolnai E, Nagy B Jr, Nagy B, Balla G, Balla J, Jeney V (2016) Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta 1862(9):1640–1649. https://doi.org/10.1016/j.bbadis.2016.06.003
Chen B, Yan YL, Liu C, Bo L, Li GF, Wang H, Xu YJ (2014) Therapeutic effect of deferoxamine on iron overload-induced inhibition of osteogenesis in a zebrafish model. Calcif Tissue Int 94(3):353–360. https://doi.org/10.1007/s00223-013-9817-4
Zhang AS, Enns CA (2009) Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem 284(2):711–715. https://doi.org/10.1074/jbc.R800017200
Camaschella C (2015) Iron-deficiency anemia. N Engl J Med 372(19):1832–1843. https://doi.org/10.1056/NEJMra1401038
Fuqua BK, Vulpe CD, Anderson GJ (2012) Intestinal iron absorption. J Trace Elem Med Biol 26(2–3):115–119. https://doi.org/10.1016/j.jtemb.2012.03.015
Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1(3):191–200. https://doi.org/10.1016/j.cmet.2005.01.003
Frazer DM, Anderson GJ (2014) The regulation of iron transport. Biofactors 40(2):206–214. https://doi.org/10.1002/biof.1148
Theil EC (2013) Ferritin: the protein nanocage and iron biomineral in health and in disease. Inorg Chem 52(21):12223–12233. https://doi.org/10.1021/ic400484n
Drakesmith H, Nemeth E, Ganz T (2015) Ironing out ferroportin. Cell Metab 22(5):777–787. https://doi.org/10.1016/j.cmet.2015.09.006
Lakhal-Littleton S, Wolna M, Carr CA, Miller JJ, Christian HC, Ball V, Santos A, Diaz R, Biggs D, Stillion R, Holdship P, Larner F, Tyler DJ, Clarke K, Davies B, Robbins PA (2015) Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci U S A 112(10):3164–3169. https://doi.org/10.1073/pnas.1422373112
Mayle KM, Le AM, Kamei DT (2012) The intracellular trafficking pathway of transferrin. Biochim Biophys Acta 1820(3):264–281. https://doi.org/10.1016/j.bbagen.2011.09.009
Recalcati S, Gammella E, Buratti P, Cairo G (2017) Molecular regulation of cellular iron balance. IUBMB Life 69(6):389–398. https://doi.org/10.1002/iub.1628
Arosio P, Levi S (2010) Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta 1800(8):783–792. https://doi.org/10.1016/j.bbagen.2010.02.005
Milto IV, Grishanova AY, Klimenteva TK, Suhodolo IV, Vasukov GY, Ivanova VV (2014) Iron metabolism after application of modified magnetite nanoparticles in rats. Biochemistry (Mosc) 79(11):1245–1254. https://doi.org/10.1134/S0006297914110121
Recalcati S, Minotti G, Cairo G (2010) Iron regulatory proteins: from molecular mechanisms to drug development. Antioxid Redox Signal 13(10):1593–1616. https://doi.org/10.1089/ars.2009.2983
Wilkinson N, Pantopoulos K (2014) The IRP/IRE system in vivo: insights from mouse models. Front Pharmacol 5:176. https://doi.org/10.3389/fphar.2014.00176
Thompson JW, Bruick RK (2012) Protein degradation and iron homeostasis. Biochim Biophys Acta 1823(9):1484–1490. https://doi.org/10.1016/j.bbamcr.2012.02.003
Xu W, Barrientos T, Andrews NC (2013) Iron and copper in mitochondrial diseases. Cell Metab 17(3):319–328. https://doi.org/10.1016/j.cmet.2013.02.004
Peyssonnaux C, Nizet V, Johnson RS (2008) Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle 7(1):28–32. https://doi.org/10.4161/cc.7.1.5145
Hou Y, Zhang S, Wang L, Li J, Qu G, He J, Rong H, Ji H, Liu S (2012) Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 511(2):398–403. https://doi.org/10.1016/j.gene.2012.09.060
Park CH, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. https://doi.org/10.1074/jbc.M008922200
Zhao N, Zhang AS, Enns CA (2013) Iron regulation by hepcidin. J Clin Invest 123(6):2337–2343. https://doi.org/10.1172/JCI67225
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090–2093. https://doi.org/10.1126/science.1104742
Anderson GJ, Frazer DM (2017) Current understanding of iron homeostasis. Am J Clin Nutr 106(Suppl 6):1559S–1566S. https://doi.org/10.3945/ajcn.117.155804
Mendel GA (1961) Studies on iron absorption. I. The relationships between the rate of erythropoiesis, hypoxia and iron absorption. Blood 18:727–736
Ganz T (2019) Erythropoietic regulators of iron metabolism. Free Radic Biol Med 133:69–74. https://doi.org/10.1016/j.freeradbiomed.2018.07.003
Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T (2014) Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 46(7):678–684. https://doi.org/10.1038/ng.2996
Wang CY, Core AB, Canali S, Zumbrennen-Bullough KB, Ozer S, Umans L, Zwijsen A, Babitt JL (2017) Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice. Blood 130(1):73–83. https://doi.org/10.1182/blood-2016-12-759423
Murphy CJ, Oudit GY (2010) Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. J Card Fail 16(11):888–900. https://doi.org/10.1016/j.cardfail.2010.05.009
Andrews NC (2008) Forging a field: the golden age of iron biology. Blood 112(2):219–230. https://doi.org/10.1182/blood-2007-12-077388
Sawicki KT, Shang M, Wu R, Chang HC, Khechaduri A, Sato T, Kamide C, Liu T, Naga Prasad SV, Ardehali H (2015) Increased heme levels in the heart lead to exacerbated ischemic injury. J Am Heart Assoc 4(8):e002272. https://doi.org/10.1161/JAHA.115.002272
Khechaduri A, Bayeva M, Chang HC, Ardehali H (2013) Heme levels are increased in human failing hearts. J Am Coll Cardiol 61(18):1884–1893. https://doi.org/10.1016/j.jacc.2013.02.012
Xu W, Barrientos T, Mao L, Rockman HA, Sauve AA, Andrews NC (2015) Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep 13(3):533–545. https://doi.org/10.1016/j.celrep.2015.09.023
Chang HC, Wu R, Shang M, Sato T, Chen C, Shapiro JS, Liu T, Thakur A, Sawicki KT, Prasad SV, Ardehali H (2016) Reduction in mitochondrial iron alleviates cardiac damage during injury. EMBO Mol Med 8(3):247–267. https://doi.org/10.15252/emmm.201505748
Kali A, Kumar A, Cokic I, Tang RL, Tsaftaris SA, Friedrich MG, Dharmakumar R (2013) Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation. Circ Cardiovasc Imaging 6(2):218–228. https://doi.org/10.1161/CIRCIMAGING.112.000133
Carberry J, Carrick D, Haig C, Ahmed N, Mordi I, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay M, Davie A, Mahrous A, Ford I, Sattar N, Welsh P, Radjenovic A, Oldroyd KG, Berry C (2018) Persistent iron within the infarct core after ST-segment elevation myocardial infarction: implications for left ventricular remodeling and health outcomes. JACC Cardiovasc Imaging 11(9):1248–1256. https://doi.org/10.1016/j.jcmg.2017.08.027
Singh N, Haldar S, Tripathi AK, Horback K, Wong J, Sharma D, Beserra A, Suda S, Anbalagan C, Dev S, Mukhopadhyay CK, Singh A (2014) Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal 20(8):1324–1363. https://doi.org/10.1089/ars.2012.4931
Rouault TA (2013) Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 14(8):551–564. https://doi.org/10.1038/nrn3453
Fretham SJ, Carlson ES, Georgieff MK (2011) The role of iron in learning and memory. Adv Nutr 2(2):112–121. https://doi.org/10.3945/an.110.000190
Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nunez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease. Proc Natl Acad Sci U S A 105(47):18578–18583. https://doi.org/10.1073/pnas.0804373105
Boll MC, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C (1999) Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson’s disease. Neurosci Lett 265(3):155–158
Martinez-Hernandez R, Montes S, Higuera-Calleja J, Yescas P, Boll MC, Diaz-Ruiz A, Rios C (2011) Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson’s disease patients: a pilot study. Neurochem Res 36(11):2111–2115. https://doi.org/10.1007/s11064-011-0535-x
Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer’s disease. J Neurochem 82(5):1137–1147
Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell 142(6):857–867. https://doi.org/10.1016/j.cell.2010.08.014
Williams R, Buchheit CL, Berman NE, LeVine SM (2012) Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 120(1):7–25. https://doi.org/10.1111/j.1471-4159.2011.07536.x
Lassmann H, van Horssen J, Mahad D (2012) Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol 8(11):647–656. https://doi.org/10.1038/nrneurol.2012.168
Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA (2004) Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145(11):5305–5312. https://doi.org/10.1210/en.2004-0392
Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC, Hopkins PN, Cefalu WT, McClain DA (2012) Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122(10):3529–3540. https://doi.org/10.1172/JCI44421
Kukulj S, Jaganjac M, Boranic M, Krizanac S, Santic Z, Poljak-Blazi M (2010) Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med Oncol 27(2):268–277. https://doi.org/10.1007/s12032-009-9203-2
Babu KR, Muckenthaler MU (2016) miR-20a regulates expression of the iron exporter ferroportin in lung cancer. J Mol Med (Berl) 94(3):347–359. https://doi.org/10.1007/s00109-015-1362-3
Fu Y, Chung FL (2018) Oxidative stress and hepatocarcinogenesis. Hepatoma Res 4. https://doi.org/10.20517/2394-5079.2018.29
Raza M, Chakraborty S, Choudhury M, Ghosh PC, Nag A (2014) Cellular iron homeostasis and therapeutic implications of iron chelators in cancer. Curr Pharm Biotechnol 15(12):1125–1140
Jabara HH, Boyden SE, Chou J, Ramesh N, Massaad MJ, Benson H, Bainter W, Fraulino D, Rahimov F, Sieff C, Liu ZJ, Alshemmari SH, Al-Ramadi BK, Al-Dhekri H, Arnaout R, Abu-Shukair M, Vatsayan A, Silver E, Ahuja S, Davies EG, Sola-Visner M, Ohsumi TK, Andrews NC, Notarangelo LD, Fleming MD, Al-Herz W, Kunkel LM, Geha RS (2016) A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet 48(1):74–78. https://doi.org/10.1038/ng.3465
Oexle H, Kaser A, Most J, Bellmann-Weiler R, Werner ER, Werner-Felmayer G, Weiss G (2003) Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J Leukoc Biol 74(2):287–294
Nairz M, Theurl I, Ludwiczek S, Theurl M, Mair SM, Fritsche G, Weiss G (2007) The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 9(9):2126–2140. https://doi.org/10.1111/j.1462-5822.2007.00942.x
Weiss G (2002) Iron and immunity: a double-edged sword. Eur J Clin Investig 32(Suppl 1):70–78
Camacho A, Simao M, Ea HK, Cohen-Solal M, Richette P, Branco J, Cancela ML (2016) Iron overload in a murine model of hereditary hemochromatosis is associated with accelerated progression of osteoarthritis under mechanical stress. Osteoarthr Cartil 24(3):494–502. https://doi.org/10.1016/j.joca.2015.09.007
Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C (2009) Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35(1):28–35. https://doi.org/10.1002/biof.5
Levi S, Rovida E (2009) The role of iron in mitochondrial function. Biochim Biophys Acta 1790(7):629–636. https://doi.org/10.1016/j.bbagen.2008.09.008
Medeiros DM, Stoecker B, Plattner A, Jennings D, Haub M (2004) Iron deficiency negatively affects vertebrae and femurs of rats independently of energy intake and body weight. J Nutr 134(11):3061–3067. https://doi.org/10.1093/jn/134.11.3061
Parelman M, Stoecker B, Baker A, Medeiros D (2006) Iron restriction negatively affects bone in female rats and mineralization of hFOB osteoblast cells. Exp Biol Med (Maywood) 231(4):378–386
Toxqui L, Vaquero MP (2015) Chronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesis. Nutrients 7(4):2324–2344. https://doi.org/10.3390/nu7042324
Zofkova I, Davis M, Blahos J (2017) Trace elements have beneficial, as well as detrimental effects on bone homeostasis. Physiol Res 66(3):391–402
Lu W, Zhao M, Rajbhandary S, Xie F, Chai X, Mu J, Meng J, Liu Y, Jiang Y, Xu X, Meng A (2013) Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients. Eur J Haematol 91(3):249–261. https://doi.org/10.1111/ejh.12159
Gattermann N (2009) The treatment of secondary hemochromatosis. Dtsch Arztebl Int 106(30):499–504, I. https://doi.org/10.3238/arztebl.2009.0499
Chalès G, Guggenbuhl P (2003) When and how should we screen for hereditary hemochromatosis? Joint Bone Spine 70(4):263–270. https://doi.org/10.1016/s1297-319x(03)00035-6
Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS, American Association for the Study of Liver D (2011) Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54(1):328–343. https://doi.org/10.1002/hep.24330
Pietrangelo A (2016) Iron and the liver. Liver Int 36(Suppl 1):116–123. https://doi.org/10.1111/liv.13020
Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV (2016) Iron and cancer: recent insights. Ann N Y Acad Sci 1368(1):149–161. https://doi.org/10.1111/nyas.13008
Bystrom LM, Rivella S (2015) Cancer cells with irons in the fire. Free Radic Biol Med 79:337–342. https://doi.org/10.1016/j.freeradbiomed.2014.04.035
Xiong W, Wang L, Yu F (2014) Regulation of cellular iron metabolism and its implications in lung cancer progression. Med Oncol 31(7):28. https://doi.org/10.1007/s12032-014-0028-2
Zhang C, Zhang F (2015) Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell 6(2):88–100. https://doi.org/10.1007/s13238-014-0119-z
Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, Bongarzone I (2014) Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer. Ann Oncol 25(2):352–357. https://doi.org/10.1093/annonc/mdt490
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Guan J, Lo M, Dockery P, Mahon S, Karp CM, Buckley AR, Lam S, Gout PW, Wang YZ (2009) The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemother Pharmacol 64(3):463–472. https://doi.org/10.1007/s00280-008-0894-4
Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10(1):9–17. https://doi.org/10.1038/nchembio.1416
Woo JH, Shimoni Y, Yang WS, Subramaniam P, Iyer A, Nicoletti P, Rodriguez Martinez M, Lopez G, Mattioli M, Realubit R, Karan C, Stockwell BR, Bansal M, Califano A (2015) Elucidating compound mechanism of action by network perturbation analysis. Cell 162(2):441–451. https://doi.org/10.1016/j.cell.2015.05.056
Beard JL (2001) Iron biology in immune function, muscle metabolism and neuronal functioning
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L (2016) Iron deficiency anaemia. Lancet 387(10021):907–916. https://doi.org/10.1016/S0140-6736(15)60865-0
Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA (2013) Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 165(4):575–582 e573. https://doi.org/10.1016/j.ahj.2013.01.017
Youdim MB (2008) Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res 14(1):45–56
Kdoqi, National Kidney F (2006) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47(5 Suppl 3):S11–S145. https://doi.org/10.1053/j.ajkd.2006.03.010
Jonker FA, Boele van Hensbroek M (2014) Anaemia, iron deficiency and susceptibility to infections. J Inf Secur 69(Suppl 1):S23–S27. https://doi.org/10.1016/j.jinf.2014.08.007
Sapir-Koren R, Livshits G (2017) Postmenopausal osteoporosis in rheumatoid arthritis: the estrogen deficiency-immune mechanisms link. Bone 103:102–115. https://doi.org/10.1016/j.bone.2017.06.020
Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, Liu S, Looker AC, Wallace TC, Wang DD (2016) Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int 27(1):367–376. https://doi.org/10.1007/s00198-015-3386-5
Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW (2000) Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol 111(3):902–907
Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3):65–87. https://doi.org/10.1016/j.tox.2011.03.001
Jeney V (2017) Clinical impact and cellular mechanisms of iron overload-associated bone loss. Front Pharmacol 8. https://doi.org/10.3389/fphar.2017.00077
Matsushima S, Hoshimoto M, Torii M, Ozaki K, Narama I (2001) Iron lactate-induced osteopenia in male Sprague-Dawley rats. Toxicol Pathol 29(6):623–629. https://doi.org/10.1080/019262301753385951
Doyard M, Chappard D, Leroyer P, Roth MP, Loreal O, Guggenbuhl P (2016) Decreased bone formation explains osteoporosis in a genetic mouse model of hemochromatosiss. PLoS One 11(2):e0148292. https://doi.org/10.1371/journal.pone.0148292
Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197(2):93–100. https://doi.org/10.1016/j.tox.2003.12.006
Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116(14):2582–2589. https://doi.org/10.1182/blood-2009-12-260083
Cheng Q, Zhang X, Jiang J, Zhao G, Wang Y, Xu Y, Xu X, Ma H (2017) Postmenopausal iron overload exacerbated bone loss by promoting the degradation of type I collagen. Biomed Res Int 2017:1–9. https://doi.org/10.1155/2017/1345193
Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13(7):791–801. https://doi.org/10.1038/nm1593
Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP, Multi-Center Iron Overload Study G (2008) Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone 43(1):162–168. https://doi.org/10.1016/j.bone.2008.03.003
Hofbauer LC, Kuhne CA, Viereck V (2004) The OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskelet Neuronal Interact 4(3):268–275
Ikeda K, Takeshita S (2016) The role of osteoclast differentiation and function in skeletal homeostasis. J Biochem 159(1):1–8. https://doi.org/10.1093/jb/mvv112
Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15(3):259–266. https://doi.org/10.1038/nm.1910
Jia P, Xu YJ, Zhang ZL, Li K, Li B, Zhang W, Yang H (2012) Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. J Orthop Res 30(11):1843–1852. https://doi.org/10.1002/jor.22133
Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P, Bouvet R, Chales G, Mosser J, Loreal O, Guggenbuhl P (2012) Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells. Osteoporos Int 23(10):2435–2445. https://doi.org/10.1007/s00198-011-1871-z
Messer JG, Kilbarger AK, Erikson KM, Kipp DE (2009) Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone 45(5):972–979. https://doi.org/10.1016/j.bone.2009.07.073
Yamasaki K, Hagiwara H (2009) Excess iron inhibits osteoblast metabolism. Toxicol Lett 191(2–3):211–215. https://doi.org/10.1016/j.toxlet.2009.08.023
Wynnyckyj C, Omelon S, Savage K, Damani M, Chachra D, Grynpas MD (2009) A new tool to assess the mechanical properties of bone due to collagen degradation. Bone 44(5):840–848. https://doi.org/10.1016/j.bone.2008.12.014
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5):747–754
Gammella E, Recalcati S, Cairo G (2016) Dual role of ROS as signal and stress agents: iron tips the balance in favor of toxic effects. Oxidative Med Cell Longev 2016:8629024. https://doi.org/10.1155/2016/8629024
Zheng QQ, Zhao YS, Guo J, Zhao SD, Song LX, Fei CM, Zhang Z, Li X, Chang CK (2017) Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome. Leuk Res 58:55–62. https://doi.org/10.1016/j.leukres.2017.04.005
Filaire E, Toumi H (2012) Reactive oxygen species and exercise on bone metabolism: friend or enemy? Joint Bone Spine 79(4):341–346. https://doi.org/10.1016/j.jbspin.2012.03.007
Ray PD, Huang BW, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24(5):981–990. https://doi.org/10.1016/j.cellsig.2012.01.008
Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 314(1):197–207
Lee DH, Lim BS, Lee YK, Yang HC (2006) Effects of hydrogen peroxide (H2O2) on alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines. Cell Biol Toxicol 22(1):39–46. https://doi.org/10.1007/s10565-006-0018-z
Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT (2015) Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling. Calcif Tissue Int 96(4):335–346. https://doi.org/10.1007/s00223-015-9961-0
Grosbois B, Decaux O, Cador B, Cazalets C, Jego P (2005) Human iron deficiency. Bull Acad Natl Med 189(8):1649–1663 discussion 1663-1644
Balogh E, Paragh G, Jeney V (2018) Influence of iron on bone homeostasis. Pharmaceuticals (Basel) 11(4). https://doi.org/10.3390/ph11040107
Gorres KL, Raines RT (2010) Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 45(2):106–124. https://doi.org/10.3109/10409231003627991
Goltzman D (2018) Functions of vitamin D in bone. Histochem Cell Biol 149(4):305–312. https://doi.org/10.1007/s00418-018-1648-y
Shayman JA (2014) Thematic review series: recent advances in the treatment of lysosomal storage diseases. J Lipid Res 55(6):993–994. https://doi.org/10.1194/jlr.E049817
Zhao GY, Zhao LP, He YF, Li GF, Gao C, Li K, Xu YJ (2012) A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency. Biol Trace Elem Res 150(1–3):487–495. https://doi.org/10.1007/s12011-012-9511-9
Katsumata S, Katsumata-Tsuboi R, Uehara M, Suzuki K (2009) Severe iron deficiency decreases both bone formation and bone resorption in rats. J Nutr 139(2):238–243. https://doi.org/10.3945/jn.108.093757
Diaz-Castro J, Lopez-Frias MR, Campos MS, Lopez-Frias M, Alferez MJ, Nestares T, Ojeda ML, Lopez-Aliaga I (2012) Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats. Eur J Nutr 51(2):241–247. https://doi.org/10.1007/s00394-011-0212-5
Toxqui L, Perez-Granados AM, Blanco-Rojo R, Wright I, de la Piedra C, Vaquero MP (2014) Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young Spanish women. Eur J Nutr 53(2):441–448. https://doi.org/10.1007/s00394-013-0544-4
Chang K, Chang WH (2003) Pulsed electromagnetic fields prevent osteoporosis in an ovariectomized female rat model: a prostaglandin E2-associated process. Bioelectromagnetics 24(3):189–198. https://doi.org/10.1002/bem.10078
Sert C, Mustafa D, Duz MZ, Aksen F, Kaya A (2002) The preventive effect on bone loss of 50-Hz, 1-mT electromagnetic field in ovariectomized rats. J Bone Miner Metab 20(6):345–349. https://doi.org/10.1007/s007740200050
Jing D, Cai J, Wu Y, Shen G, Li F, Xu Q, Xie K, Tang C, Liu J, Guo W, Wu X, Jiang M, Luo E (2014) Pulsed electromagnetic fields partially preserve bone mass, microarchitecture, and strength by promoting bone formation in hindlimb-suspended rats. J Bone Miner Res 29(10):2250–2261. https://doi.org/10.1002/jbmr.2260
Zhou J, Li X, Liao Y, Feng W, Fu C, Guo X (2015) Pulsed electromagnetic fields inhibit bone loss in streptozotocin-induced diabetic rats. Endocrine 49(1):258–266. https://doi.org/10.1007/s12020-014-0439-z
Yan JL, Zhou J, Ma HP, Ma XN, Gao YH, Shi WG, Fang QQ, Ren Q, Xian CJ, Chen KM (2015) Pulsed electromagnetic fields promote osteoblast mineralization and maturation needing the existence of primary cilia. Mol Cell Endocrinol 404:132–140. https://doi.org/10.1016/j.mce.2015.01.031
Zhai M, Jing D, Tong S, Wu Y, Wang P, Zeng Z, Shen G, Wang X, Xu Q, Luo E (2016) Pulsed electromagnetic fields promote in vitro osteoblastogenesis through a Wnt/beta-catenin signaling-associated mechanism. Bioelectromagnetics 37(3):152–162. https://doi.org/10.1002/bem.21961
Chang K, Chang WH, Tsai MT, Shih C (2006) Pulsed electromagnetic fields accelerate apoptotic rate in osteoclasts. Connect Tissue Res 47(4):222–228. https://doi.org/10.1080/03008200600858783
Aydin N, Bezer M (2011) The effect of an intramedullary implant with a static magnetic field on the healing of the osteotomised rabbit femur. Int Orthop 35(1):135–141. https://doi.org/10.1007/s00264-009-0932-9
Taniguchi N, Kanai S (2007) Efficacy of static magnetic field for locomotor activity of experimental osteopenia. Evid Based Complement Alternat Med 4(1):99–105. https://doi.org/10.1093/ecam/nel067
Kotani H, Kawaguchi H, Shimoaka T, Iwasaka M, Ueno S, Ozawa H, Nakamura K, Hoshi K (2002) Strong static magnetic field stimulates bone formation to a definite orientation in vitro and in vivo. J Bone Miner Res 17(10):1814–1821. https://doi.org/10.1359/jbmr.2002.17.10.1814
Qian AR, Gao X, Zhang W, Li JB, Wang Y, Di SM, Hu LF, Shang P (2013) Large gradient high magnetic fields affect osteoblast ultrastructure and function by disrupting collagen I or fibronectin/alphabeta1 integrin. PLoS One 8(1):e51036. https://doi.org/10.1371/journal.pone.0051036
Yang J, Zhang J, Ding C, Dong D, Shang P (2018) Regulation of osteoblast differentiation and iron content in MC3T3-E1 cells by static magnetic field with different intensities. Biol Trace Elem Res 184(1):214–225. https://doi.org/10.1007/s12011-017-1161-5
Zhang J, Ding C, Shang P (2014) Alterations of mineral elements in osteoblast during differentiation under hypo, moderate and high static magnetic fields. Biol Trace Elem Res 162(1–3):153–157. https://doi.org/10.1007/s12011-014-0157-7
Wu D, Wen X, Liu W, Hu H, Ye B, Zhou Y (2018) Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload. Drug Des Devel Ther 12:1081–1091. https://doi.org/10.2147/DDDT.S161086
Zhao Q, Shen X, Zhang W, Zhu G, Qi J, Deng L (2012) Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone 50(3):763–770. https://doi.org/10.1016/j.bone.2011.12.003
Chung JH, Kim YS, Noh K, Lee YM, Chang SW, Kim EC (2014) Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway. J Periodontal Res 49(5):563–573. https://doi.org/10.1111/jre.12136
Zhang J, Zheng L, Wang Z, Pei H, Hu W, Nie J, Shang P, Li B, Hei TK, Zhou G (2019) Lowering iron level protects against bone loss in focally irradiated and contralateral femurs through distinct mechanisms. Bone 120:50–60. https://doi.org/10.1016/j.bone.2018.10.005
Xu Z, Sun W, Li Y, Ling S, Zhao C, Zhong G, Zhao D, Song J, Song H, Li J, You L, Nie G, Chang Y, Li Y (2017) The regulation of iron metabolism by hepcidin contributes to unloading-induced bone loss. Bone 94:152–161. https://doi.org/10.1016/j.bone.2016.09.023
Chiu PF, Ko SY, Chang CC (2012) Vitamin C affects the expression of hepcidin and erythropoietin receptor in HepG2 cells. J Ren Nutr 22(3):373–376. https://doi.org/10.1053/j.jrn.2011.09.007
Deyhim F, Strong K, Deyhim N, Vandyousefi S, Stamatikos A, Faraji B (2019) Vitamin C reverses bone loss in an osteopenic rat model of osteoporosis. Int J Vitam Nutr Res:1–8. https://doi.org/10.1024/0300-9831/a000486
Shen CL, Chyu MC, Wang JS (2013) Tea and bone health: steps forward in translational nutrition. Am J Clin Nutr 98(6 Suppl):1694S–1699S. https://doi.org/10.3945/ajcn.113.058255
Shen CL, Yeh JK, Cao JJ, Wang JS (2009) Green tea and bone metabolism. Nutr Res 29(7):437–456. https://doi.org/10.1016/j.nutres.2009.06.008
Chen K, Qiu P, Yuan Y, Zheng L, He J, Wang C, Guo Q, Kenny J, Liu Q, Zhao J, Chen J, Tickner J, Fan S, Lin X, Xu J (2019) Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species. Theranostics 9(6):1634–1650. https://doi.org/10.7150/thno.30206
Jing X, Du T, Chen K, Guo J, Xiang W, Yao X, Sun K, Ye Y, Guo F (2019) Icariin protects against iron overload-induced bone loss via suppressing oxidative stress. J Cell Physiol 234(7):10123–10137. https://doi.org/10.1002/jcp.27678
Acknowledgments
We would like to thank Dr. Xu-Hui Li for the suggestions and comments. We thank Dr. Debiroundtree for the language support.
Funding
This review is supported by the National Natural Science Foundation of China (51777171), the Fundamental Research Funds for the Central Universities (3102017OQD111), the Northwestern Polytechnical University Foundation for Fundamental Research (3102018JGC012), and the Science and Technology Planning Project of Shenzhen of China (JCYJ20170412140904406).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Che, J., Yang, J., Zhao, B. et al. The Effect of Abnormal Iron Metabolism on Osteoporosis. Biol Trace Elem Res 195, 353–365 (2020). https://doi.org/10.1007/s12011-019-01867-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-019-01867-4